Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis

Gut

Volumn 35, Issue 9, 1994, Pages 1311-1315

  Heath, D I ^a,c   Wilson, C ^a   Gudgeon, A M ^b   Jehanli, A ^b   Shenkin, A ^a   Imrie, C W ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; APROTININ; PEPTIDE;

ACUTE PANCREATITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; PANCREAS NECROSIS; PATIENT SELECTION; PERITONEAL FLUID; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028146520     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.35.9.1311     Document Type: Article

References (41)

1. Uhl W, Buchler M, Malfertheiner P, Martini M, Berger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-9.
2. Bradley EL, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg 1989; 210: 495-503.
3. Leger L, Chiche B, Louvel A. Pancreatic necrosis and acute pancreatitis. World J Surg 1981; 5: 315-7.
4. Hollender LF, Meyer C, Keller D. Planned operation for necrotising pancreatitis: the continental experience. In: Howard JM, Jordan GL, Reber HA, eds. Surgical diseases of the pancreas. 1986. Philadelphia: Lea & Febinger, 450-60.
5. Nordback I, Pessi T, Auvinen O, Autio V. Determination of necrosis in necrotizing pancreatitis. Br J Surg 1985; 72: 225-7.
6. Edelman G, Boutelier P. Le Traitement Des Pancreatities Aigues Necrosantes Par L'ablation Chirurgicale Precoce Des Portions Necrosees. Chirurgie 1974; 100: 155-9.
7. Kivilaakson E, Fraki O, Nikki P, Lempinen M. Resection of the pancreas for acute fulmunant pancreatitis. Surg Gynecol Obstet 1981; 152: 493-8.
8. Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreastic necrosis. A prospective clinical study. Gastroenterology 1986; 91: 433-8.
9. Hermon Taylor J, Heywood GC. A rational approach to the specific chemotherapy of pancreatitis. Scand J Gastroenterol Suppl 1985; 117: 39-46.
10. Rinderknecht H. Activation of pancreatic zymogens: normal activation, premature intrapencreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986; 24: 80-6.
11. O'Conner CM, O'Donnell MD, McGeeney KF. Problems associated with the radioimmunoassay of serum trypsin. Clin Chim Acta 1980; 114: 29-35.
12. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetraaspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988; 111: 195-203.
13. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8.
14. Lavin M, Wilson C, Heath D, Alexander D, Imrie CW, McMahon MJ. Intraperitoneal aprotinin therapy and the clinical course of acute pancreatitis. Br J Surg 1992; 79: 456-7.
15. McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg 1980; 67: 22-5.
16. Gardner MJ, Altman DG. Statistics with confidence - confidence intervals and statistical guidelines. London: BMJ Publishing Group, 1989.
17. Teerenhovi O, Nordback I, Isolauri J. Ranson signs and necrosis of the pancreas in acute necrotising pancreatitis. Acta Chir Scand 1988; 154: 385-8.
18. Leese T, Shaw D, Holliday M. Prognostic markers in acute pancreatitis: can pancreatic necrosis be predicted? Ann R Coll Surg Engl 1988; 70: 227-32.
19. Corfield AP, Cooper MJ, Williamson RC, Mayer AD, McMahon MJ, Dickson AP, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985; ii: 403-7.
20. Block S, Maier W, Bittner R, Buchler M, Malfertheiner P, Beger HG. Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut 1986; 27: 1035-42.
21. Warshaw AL, Lee KH. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 1979; 86: 227-34.
22. Warshaw AL, Fournier P. Release of ribonuclease from anoxic pancreas. Surgery 1984; 95: 537-40.
23. Buchler M, Malfertheiner P, Beger HG. Correlation of imaging procedures, biochemical parameters and clinical stage in acute pancreatitis. In: Malfertheiner P, Ditschuneit H, eds. Diagnostic procedures in pancreatic disease. Berlin: Springer-Verlag, 123-9.
24. Edmondson HA, Berne CJ. Calcium changes in acute pancreatic necrosis. Surg Gynecol Obstet 1944; 79: 240-4.
25. Edmondson HA, Berne CJ, Homann RE, Wertman M. Calcium, potassium, magnesium and amylase disturbances in acute pancreatitis. Am J Med 1952; 12: 34-42.
26. Puolakkainen P, Valtonen V, Paananen A, Schroder T. C-reactive protein (CPR) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987; 28: 764-71.
27. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177-81.
28. Kemmer TP, Malfertheiner P, Buchler M, Kemmer ML, Ditschuneit H. Serum ribonuclease activity in the diagnosis of pancreatic disease. Int J Pancreatol 1991; 8: 23-33.
29. Swobodnik W. Controversies and limitations of ultrasonography in acute pancreatitis. In: Malfertheiner P, Ditschuneit H, eds. Diagnostic procedures in pancreatic disease. Berlin: Springer-Verlag, 1986: 32-6.
30. Kivisaar L, Somer K, Standertskjold Nordenstam CG, Schroder T, Kivilaakso E, et al. A new method for the diagnosis of acute hemorrhagic-necrotizing pancreatitis using contrast-enhanced CT. Gastrointest Radiol 1984; 9: 27-30.
31. Nuutinen P, Kivisaari L, Schroder T. Contrast-enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis. Pancreas 1988; 3: 53-60.
32. Larvin M, Chalmers AG, McMahon MJ. Dynamic contrast enhanced computed tomography: a precise technique for identifying and localising pancreatic necrosis. BMJ 1990; 300: 1425-8.
33. Larvin M, McMahon MJ. 'Prune Juice' peritoneal fluid in patients with acute pancreatitis: is the pancreas necrotic? Gut 1986; 27: A230-1.
34. Fernandez del Castillo C, Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Jehanli A, et al. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat. Pancreas 1992; 7: 263-70.
35. Schmidt J, Fernandez del Castillo C, Rattner DW, Lewandrowski K, Compton CC, Warshaw AL. Trypsinogen activation peptides in experimental rat pancreatitis: prognostics and histopathological correlates. Gastroenterology 1993; 103: 1009-16.
36. Yamaguchi H, Kimura T, Mimura K, Nawata H. Activation of proteases in caerulin-induced pancreatitis. Pancreas 1989; 4: 565-71.
37. White TT, Heimbach DM. Sequestrectomy and hyperalimentation in the treatment of hemorrhagic pancreatitis. Am J Surg 1976; 132: 270-5.
38. Smadja C, Bismuth H. Acute necrotic pancreatitis: toward restriction of surgical indications. Gastroenterol Clin Biol 1984; 8: 536-40.
39. Beger HG. Management of pancreatic necrosis and pancreatic abscess. In: Carter DC, Warshaw AI, eds. Pancreatitis. Edinburgh: Churchill Livingstone, 1989.
40. Larvin M, McMahon MJ, APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; ii: 201-5.
41. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77: 1260-4.